Evidence map›Paper›PMID 31462594›Full record

ReviewInternal medicine (Tokyo, Japan)2020

Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.

Masahiko Sumi, Mari Kitahara, Tsutomu Shishido, Hiroko Kazumoto, Nozomu Uematsu, Takehiko Kirihara, Keijiro Sato, Toshimitsu Ueki, Yuki Hiroshima, Kunihiko Shimizu and 1 more

Open access · diamondAbstract readCase ReportsReview
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Masahiko SumiDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Mari KitaharaDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Tsutomu ShishidoDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Hiroko KazumotoDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Nozomu UematsuDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Takehiko KiriharaDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Keijiro SatoDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Toshimitsu UekiDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Yuki HiroshimaDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Kunihiko ShimizuDepartment of Cardiology, Nagano Red Cross Hospital, Japan.
Hikaru KobayashiDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Nagano Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.

Indexed as

Cord Blood Stem Cell TransplantationAtrioventricular BlockFemaleGlucocorticoidsGraft vs Host DiseaseHumansMiddle AgedMyocarditisPrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoloneShock, CardiogenicGlucocorticoidsPrednisoloneallogeneic stem cell transplantationatrioventricular blockgraft-versus-host diseasemyocarditis

Identifiers

PMID31462594
PMCPMC6995704
OpenAlexW2970011820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.